Fertility-Sparing Surgery in Gynecologic Cancer: A Systematic Review
| Autor: | Nienke E. van Trommel, Winnie Schats, Sanne Samuels, Frédéric Amant, Teska Schuurman, Sanne Zilver, Christianne A.R. Lok |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Cancer Research
medicine.medical_specialty trachelectomy cervical cancer media_common.quotation_subject MEDLINE Fertility Cochrane Library lcsh:RC254-282 conization 03 medical and health sciences 0302 clinical medicine fertility-sparing surgery medicine media_common Cervical cancer Science & Technology hormonal therapy 030219 obstetrics & reproductive medicine business.industry Endometrial cancer General surgery Retrospective cohort study lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens medicine.disease ovarian cancer Oncology 030220 oncology & carcinogenesis endometrial cancer Hormonal therapy Systematic Review Ovarian cancer business Life Sciences & Biomedicine adolescents and young adults |
| Zdroj: | Cancers Cancers, Vol 13, Iss 1008, p 1008 (2021) |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers13051008 |
| Popis: | Simple Summary In Adolescents and Young Adults (AYAs), fertility is an important factor for good quality of life. In the case of cancer of the female reproductive tract, treatment can impair fertility and therefore, AYAs may face the life-changing decision whether or not to undergo conservative, fertility-sparing cancer treatment. Solid evidence on the safety as well as reproductive outcomes of these treatments is necessary to provide patients the information they need to make a well-informed choice. This systematic review aims to provide an overview of the best evidence available on both oncological and reproductive outcome after various fertility-sparing surgical options in cervical, ovarian, and endometrial cancer. Abstract Fertility-sparing surgery (FSS) is increasingly being offered to women with a gynecological malignancy who wish to preserve fertility. In this systematic review, we evaluate the best evidence currently available on oncological and reproductive outcome after FSS for early stage cervical cancer, epithelial ovarian cancer, and endometrial cancer. An extensive literature search was conducted using the electronic databases Medline (OVID), Embase, and Cochrane Library to identify eligible studies published up to December 2020. In total, 153 studies were included with 7544, 3944, and 1229 patients who underwent FSS for cervical, ovarian, and endometrial cancer, respectively. We assessed the different FSS techniques that are available to preserve fertility, i.e., omitting removal of the uterine body and preserving at least one ovary. Overall, recurrence rates after FSS are reassuring and therefore, these conservative procedures seem oncologically safe in the current selection of patients with low-stage and low-grade disease. However, generalized conclusions should be made with caution due to the methodology of available studies, i.e., mostly retrospective cohort studies with a heterogeneous patient population, inducing selection bias. Moreover, about half of patients do not pursue pregnancy despite FSS and the reasons for these decisions have not yet been well studied. International collaboration will facilitate the collection of solid evidence on FSS and the related decision-making process to optimize patient selection and counseling. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|